Loading
Latest filing published 11 Aug 2026 for Braveheart Bio, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
AH Bio Fund IV, L.P. is a declared insider of Braveheart Bio, Inc., with filings sourced from SEC (Form 4). Altogether 2 filings, all relating to 7 August 2026.
No open-market sale appears; the market trades are 1 purchase worth €17.2M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
Most recently, on 11 August 2026, the filings show a transaction in Braveheart Bio, Inc. The clock since the last published purchase (11 August 2026) now reads 75 days. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations